Skip to main content

Table 1 Clinical characteristics and risk factors of 58 patients with bacteremia caused by Aeromonas species

From: Taxonomy, virulence determinants and antimicrobial susceptibility of Aeromonas spp. isolated from bacteremia in southeastern China

Clinical characteristic No (%) of all patients (n = 58) Prognosis P-value Multivariate analysis P-value
Poor (n = 16) Well (n = 42) Odds ratios 95% CI
Gender        
 Male 40 (70.0) 12 (75.0) 28 (66.7) 0.752
 Female 18 (30.0) 4 (25.0) 14 (33.3)
Age, years (means ± SD) 61.1 ± 16.7 56.56 ± 14.45 62.76 ± 17.30 0.208
Age        
  < 65 30 (51.7) 10 (62.5) 20 (47.6) 0.311
 ≥ 65 28 (48.3) 6 (37.5) 22 (52.4)
Symptoms and signs        
  Fever (> 39℃) 31 6 (37.5) 25 (59.5) 0.133
  Leukocytosis 26 6 (37.5) 20 (47.6) 0.489
  Thrombocytopenia 34 13 (81.3) 21 (50) 0.031*    
  Neutropenia 19 7 (43.8) 12 (28.6) 0.271
Microbial findings        
  Monomicrobial 49 (84.5) 16 (100.0) 33 (78.6) 0.051
  Polymicrobial 9 (15.5) 0 (0.0) 9 (21.4)
Antimicrobial susceptibility        
 MDR 9 (15.5) 4 (25.0) 5 (11.9) 0.243
 Non MDR 49 (84.5) 12 (75.0) 37 (88.1)
 Source of infection        
  Community acquired 34 (58.6) 13 (81.3) 21 (50) 0.031* 3.201 0.57–18.00 0.187
  Nosocomial infection 24 (41.4) 3 (18.8) 21 (50)
Co-morbidity        
 Liver cirrhosis 26 (44.8) 11 (68.8) 15 (35.7) 0.024* 7.41 1.32–41.55 0.023*
  Diabetes mellitus 7 (12.1) 2 (12.5) 5 (11.9) 1.000
 Malignancy 18 (31.0) 6 (37.5) 12 (28.6) 0.538
  Leukemia 8 (13.8) 3 (18.8) 5 (1.9) 0.672
Treatment        
 inappropriate empirical antimicrobials 15 (25.9) 10 (62.5) 5 (11.9) 0.000* 16.91 3.04–94.22 0.001*
Clinical outcomes        
 Septic shock 14 11 (68.8) 3 (7.1) 0.000*
  Admission to ICU 10 9 (90) 1 (2.4) 0.000*
 Length of stay in hospital, days 17 (6–24.75) 2.5 (1–6) 19 (11.25–30) 0.000*
  1. Values are presented as No. (%), mean ± SD or median (25th–75th percentile) of patients. * significant